Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000289539 | SCV000458280 | uncertain significance | Hermansky-Pudlak syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000612645 | SCV000711279 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Ala960Ala in exon 24 of AP3B1: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 0.4% (32/8600) of E uropean American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs62001052). |
Labcorp Genetics |
RCV000640588 | SCV000762182 | benign | Hermansky-Pudlak syndrome 2 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Johns Hopkins Genomics, |
RCV000640588 | SCV000992354 | benign | Hermansky-Pudlak syndrome 2 | 2019-04-23 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002263641 | SCV002542912 | benign | Autoinflammatory syndrome | 2021-03-25 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000612645 | SCV001921054 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727701 | SCV001973171 | likely benign | not provided | no assertion criteria provided | clinical testing |